Table 2 Distribution of EQ-5D-5L and FACT-B scores and subscales at baseline and follow-up
Observed Scores | Mean | SD | Min | Q1 | Median | Q3 | Max | Lower bound | Upper bound |
|---|---|---|---|---|---|---|---|---|---|
Baseline (N = 238) | |||||||||
EQ-5D-5L utility index | |||||||||
Japanese value set | 0.777 | 0.163 | 0.179 | 0.686 | 0.740 | 0.843 | 1.000 | 0 (0.0%) | 59 (24.8%) |
UK value set | 0.785 | 0.200 | −0.283 | 0.721 | 0.777 | 0.906 | 1.000 | 0 (0.0%) | 59 (24.8%) |
FACT-B | |||||||||
Total score | 103.0 | 20.8 | 45 | 90 | 104 | 119 | 140 | 0 (0.0%) | 0 (0.0%) |
FACT-G score | 81.3 | 16.9 | 35 | 71 | 83 | 95 | 108 | 0 (0.0%) | 4 (1.7%) |
Trial outcome index | 62.8 | 14.9 | 16 | 53 | 64 | 74 | 89 | 0 (0.0%) | 0 (0.0%) |
Physical well-being | 21.1 | 6.0 | 1 | 18 | 22 | 26 | 28 | 0 (0.0%) | 29 (12.2%) |
Social well-being | 22.2 | 6.1 | 0 | 20 | 24 | 27 | 28 | 3 (1.3%) | 50 (21.0%) |
Emotional well-being | 18.0 | 4.7 | 4 | 15 | 19 | 22 | 24 | 0 (0.0%) | 28 (11.8%) |
Functional well-being | 20.0 | 6.7 | 0 | 16 | 21 | 26 | 28 | 3 (1.3%) | 31 (13.0%) |
Breast cancer subscale | 21.7 | 6.1 | 5 | 17 | 22 | 27 | 36 | 0 (0.0%) | 1 (0.4%) |
Follow-up (N = 221) | |||||||||
EQ-5D-5L utility index | |||||||||
Japanese value set | 0.758 | 0.160 | 0.052 | 0.649 | 0.740 | 0.829 | 1.000 | 0 (0.0%) | 46 (20.8%) |
UK value set | 0.770 | 0.193 | −0.283 | 0.679 | 0.768 | 0.879 | 1.000 | 0 (0.0%) | 46 (20.8%) |
FACT-B | |||||||||
Total score | 101.2 | 22.2 | 27 | 85 | 103 | 118 | 140 | 0 (0.0%) | 0 (0.0%) |
FACT-G score | 79.6 | 18.0 | 20 | 67 | 82 | 94 | 108 | 0 (0.0%) | 5 (2.3%) |
Trial outcome index | 61.6 | 15.8 | 9 | 51 | 63 | 74 | 89 | 0 (0.0%) | 0 (0.0%) |
Physical well-being | 21.0 | 6.1 | 0 | 17 | 22 | 26 | 28 | 2 (0.9%) | 26 (11.8%) |
Social well-being | 21.7 | 5.5 | 4 | 18 | 22 | 27 | 28 | 0 (0.0%) | 40 (18.1%) |
Emotional well-being | 17.9 | 4.7 | 3 | 15 | 19 | 21 | 24 | 0 (0.0%) | 25 (11.3%) |
Functional well-being | 19.0 | 6.9 | 2 | 14 | 21 | 25 | 28 | 0 (0.0%) | 20 (9.0%) |
Breast cancer subscale | 21.6 | 6.2 | 7 | 17 | 22 | 26 | 35 | 0 (0.0%) | 0 (0.0%) |